Series A Round

CND Life Sciences is a neurodiagnostics startup focused on advancing the understanding and treatment of neurological disorders through innovative diagnostic solutions. The company aims to enhance diagnostic accuracy and patient outcomes through its cutting-edge technologies. Their current focus includes developing a skin biopsy diagnostic tool for dementia and other related disorders, with ongoing clinical trials to validate their innovative approaches.